CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland.
| Revenue (Most Recent Fiscal Year) | $28.54M |
| Net Income (Most Recent Fiscal Year) | $-39.26M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.43 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -175.56% |
| Net Margin (Trailing 12 Months) | -183.93% |
| Return on Equity (Trailing 12 Months) | -972.55% |
| Return on Assets (Trailing 12 Months) | -131.54% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.30 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.24 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 4.47 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.12 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.67 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.56 |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.01 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 12.30M |
| Free Float | 9.69M |
| Market Capitalization | $11.56M |
| Average Volume (Last 20 Days) | 0.03M |
| Beta (Past 60 Months) | 0.90 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 21.24% |
| Percentage Held By Institutions (Latest 13F Reports) | 22.23% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |